Atorvastatin/CoenzymeQ10 in Congestive Heart Failure

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study is to compare the effect of addition of combination of Atorvastatin/CoenzymeQ10 to standard congestive heart failure (CHF) treatment versus addition of Atorvastatin alone on CHF outcomes.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Isfahan University of Medical Sciences
• Treatments: Atorvastatin; Atorvastatin Calcium; Coenzyme Q10; Ubiquinone

Criteria

Inclusion Criteria:

• Documented Congestive hear failure

• Ejection Fraction less than 40 percent

• Compensated heart failure without hospital admission during previous three months

• No change in type and dose of medications in the last months

• New York Heart Association Function Class 2 to 4

Exclusion Criteria:

• Acute coronary syndrome developing in the last month

• Active myocarditis

• Active pericarditis

• Uncontrolled hypertension

• Hepatic failure(Child B,C)

• Pulmonary failure

• Renal failure

• Heart failure with KILLIP classification 3 and 4